EN
HI

Godavari Drugs Share price

GODAVARI

87.98

1.32 (1.52%)
Last updated on 3 Oct, 2025 | 15:54 IST
BUYSELL
Today's High

89.00

Today's Low

87.10

52 Week Low

79.00

52 Week High

142.50

The current prices are delayed, login to your account for live prices

Godavari Drugs Share Key Metrics

Volume
3662.00
Market Cap
66.25 CR
LTQ@LTP
20@87.98
ATP
88.29
Var Margin
25 %
Circuit Range
69.33-103.99
Delivery %
0 %
Value
3.23 L
ASM/GSM
No
Market Lot
1

Godavari Drugs Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

38.26

Sector P/B

3.59

Sec. Div. Yield

0.55

Godavari Drugs Resistance and Support

Pivot 95.47

Resistance

First Resistance

96.44

Second Resistance

97.96

Third Resistance

98.93

Support

First Support

93.95

Second Support

92.98

Third Support

91.46

Godavari Drugs Futures & Options

Data Not Found

Godavari Drugs Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

52.63%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0.5%

Retail

46.87%

Others

0%

Total Promoters
MAR '25
52.63%
JUN '25
52.63%

Godavari Drugs Corporate Actions

DateAgenda
2025-08-13Quarterly Results & A.G.M.
2025-05-29Audited Results
2025-02-12Quarterly Results
2024-11-14Quarterly Results
2024-08-14Quarterly Results

Godavari Drugs News

No Data Found

About Godavari Drugs

NSE : 0  
BSE : 530317  
ISIN : INE362C01012  

GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC) Nanded a notified class ''C'' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989.MAIN OBJECTS OF THE COMPANY:The main objects at the Company as detailed in the Memorandum at Association of the Company are:1. To manufacture refine purchase sell prepare import export all classes and kinds of drugs including pharmaceutical preparations and formulations fine organics and inorganic chemicals raw materials and intermediates for drugs.2. To manufacture and/or deal in all types at drugs chemicals pharmaceuticals and intermediates on loan licence basis. 3. To undertake promote encourage initiate assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance monetary or otherwise as may be required for the purpose.

Read More

Godavari Drugs Management

NamePosition
Mr. Ghanshyam Jaju Chairman
Mr. Mukund Kakani Managing Director
View More

Godavari Drugs FAQs

The Buying Price of Godavari Drugs share is 87.98 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Godavari Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Godavari Drugs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Godavari Drugs shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Godavari Drugs shares is 0. Useful to assess the stock's value relative to its book value.

To assess Godavari Drugs’s valuation compare Sector P/E, P/B which are 38.26 & 3.59 with sector averages, along with growth rates and financial metrics.

The Market Cap of Godavari Drugs is 66.25 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Godavari Drugs share price is 142.50 & 79.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Godavari Drugs belongs to the Healthcare sector.